Work

Immunogenicity and pharmacokinetics of guselkumab among patients with moderate‐to‐severe psoriasis in VOYAGE‐1 and VOYAGE‐2

Year: 2023

Type: article

Abstract: Immunogenicity and pharmacokinetics of guselkumab among patients with moderate-

Source: Journal of the European Academy of Dermatology and Venereology

DOI: 10.1111/jdv.19309

Authors: A. Armstrong, K. Eyerich, C. Conrad, Y. Zhu, Y.‐W. Yang, M. Miller, Y. You, Y.‐K. Shen, P. Foley, C. E. M. Griffiths, B. Strober

Institutions: University of Southern California, University of Freiburg, Centre Hospitalier Universitaire Vaudois, Hôpital Orthopédique de la Suisse Romande, The University of Melbourne, St Vincent's Hospital Melbourne, Skin Health Institute, King's College London, University of Manchester, King's College Hospital, NIHR Manchester Biomedical Research Centre, Yale University

Language: English

Topic: Psoriasis: Treatment and Pathogenesis

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,940

Funder: Janssen Research and Development

OpenAlex ID: W4383483359

FWCI: 0.266

Cites: 11

Cited by: 3

Related to: 10